Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas
Open Access
- 1 October 1994
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (4) , 585-590
- https://doi.org/10.1038/bjc.1994.355
Abstract
Immunocytochemistry (ICC) has been used routinely to stain for p53 overexpression in a range of human tumours. The underlying assumption has been that positive staining indicates a mutation in the p53 coding sequence. Recently, however, discordancy has been observed and the accuracy of ICC as a marker of p53 gene mutation has been questioned. In this study of 109 colorectal adenocarcinomas, we compared ICC staining with p53 gene mutations detected by single-strand conformation polymorphism (SSCP) analysis. Concordancy between the two techniques was found in 69% of tumours. ICC-positive/SSCP-negative cases accounted for 20% of tumours and ICC-negative/SSCP-positive cases for the remaining 11%. These results caution against the assumption that p53 protein overexpression is always associated with a gene mutation. Epigenetic phenomena may account for a significant proportion of ICC-positive tumours.Keywords
This publication has 47 references indexed in Scilit:
- Current status of adjuvant chemotherapy for colorectal cancer: Can molecular markers play a role in predicting prognosis?Cancer, 1992
- Prognostic significance of p53 overexpression in gastric and colorectal carcinomaBritish Journal of Cancer, 1992
- Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.1992
- Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.1992
- Molecular Genetic Studies of Tumor suppressor Gene Regions on chromosomes 13 and 17 in Colorectal TumorsJNCI Journal of the National Cancer Institute, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.1992
- P53 in tumour pathology: Can we trust immunocytochemistry?The Journal of Pathology, 1992
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992